Genotypic Characteristics and Antimicrobial Resistance of Escherichia coli ST141 Clonal Group

Author:

Emery Audrey12ORCID,Hocquet Didier13,Bonnet Richard45,Bertrand Xavier13ORCID

Affiliation:

1. Hygiène Hospitalière, CHU, 25030 Besançon, France

2. Bactériologie, CHU Nice, 06202 Nice, France

3. Chrono-Environnement, UMR 6249, CNRS Université de Franche-Comté, 25000 Besançon, France

4. UMR 1071, Université d’Auvergne, 63000 Clermont-Ferrand, France

5. Bactériologie, CHU Clermont-Ferrand, 63000 Clermont-Ferrand, France

Abstract

Escherichia coli ST141 is one of the ExPEC lineages whose incidence is rising in France, even if no epidemic situation involving multidrug resistant isolates has been reported so far. Nonetheless, in a 2015–2017 monocentric study conducted in our French University hospital, ST141 was the most frequent lineage after ST131 in our collection of phylogroup B2 ESBL-producing E. coli. The genomes of 187 isolates representing ST141 group, including 170 genomes from public databases and 17 from our local collection, of which 13 produced ESBL, were analyzed to infer the maximum likelihood phylogeny SNP-based (Single Nucleotide Polymorphism) free-recombinant tree defining the ST141 population structure. Genomes were screened for genes encoding virulence factors (VFs) and antimicrobial resistance (AMR). We also evaluated the distribution of isolates according to their origin (host, disease, country) and the distribution of VFs or AMR genes. Finally, the phylogenic tree revealed that ST141 isolates clustered into two main sublineages, with low genetic diversity. Contrasting with a highly virulent profile, as many isolates accumulated VFs, the prevalence of AMR was limited, with no evidence of multidrug resistant emerging lineage. However, our results suggest that surveillance of this clonal group, which has the potential to spread widely in the community, would be essential.

Funder

the Besançon University Hospital

Publisher

MDPI AG

Subject

Pharmacology (medical),Infectious Diseases,Microbiology (medical),General Pharmacology, Toxicology and Pharmaceutics,Biochemistry,Microbiology

Reference23 articles.

1. The population genetics of commensal Escherichia coli;Tenaillon;Nat. Rev. Genet.,2010

2. The population genetics of pathogenic Escherichia coli;Denamur;Nat. Rev. Genet.,2020

3. Marked increase in incidence for bloodstream infections due to Escherichia coli, a side effect of previous antibiotic therapy in the elderly;Blanc;Front. Microbiol.,2015

4. Origin and Evolution of Hybrid Shiga Toxin-Producing and Uropathogenic Escherichia coli Strains of Sequence Type 141;Gati;J. Clin. Microbiol.,2019

5. Escherichia coli ST131, an Intriguing Clonal Group;Bertrand;Clin. Microbiol. Rev.,2014

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3